85
Views
35
CrossRef citations to date
0
Altmetric
Original Research

A dynamic magnetic shift method to increase nanoparticle concentration in cancer metastases: a feasibility study using simulations on autopsy specimens

, , , , &
Pages 2907-2923 | Published online: 18 Nov 2011

References

  • Cancer Facts and Figures 2010American Cancer Society2010
  • PaganiOSenkusEWoodWInternational guidelines for management of metastatic breast cancer: can metastatic breast cancer be curedJNCI Journal of the National Cancer Institute2010
  • JainRKMolecular regulation of vessel maturationNature Medicine20039685693
  • BurkeDCarnochanPGloverCAllen-MershTGCorrelation between tumour blood flow and fluorouracil distribution in a hypovascular liver metastasis modelClin Exp Metastasis20001861762211688968
  • FukumuraDJainRKTumor microenvironment abnormalities: causes, consequences, and strategies to normalizeJ Cell Biochem200710193794917171643
  • GrayLHCongerADEbertMThe concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapyBr J Radiol19532663864813106296
  • JainRKDeterminants of tumor blood flow: a reviewCancer Res198848264126583282647
  • JainRKNormalization of tumor vasculature: an emerging concept in antiangiogenic therapyScience2005307586215637262
  • TozerGMKanthouCBaguleyBCDisrupting tumour blood vesselsNat Rev Cancer2005542343515928673
  • RudnickSILouJShallerCCInfluence of affinity and antigen internalization on the uptake and penetration of anti-HER2 antibodies in solid tumorsCancer Res201171225021406401
  • HatakeyamaHAkitaHIshidaETumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomesInt J Pharm200734219420017583453
  • KirpotinDBDrummondDCShaoYAntibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal modelsCancer Res2006666732674016818648
  • IinumaHMaruyamaKOkinagaKIntracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancerInt J Cancer20029913013711948504
  • HsuJSerranoDBhowmickTEnhanced endothelial delivery and biochemical effects of [alpha]-galactosidase by ICAM-1-targeted nano-carriers for Fabry diseaseJ Control Release201114932333121047542
  • FarokhzadOCChengJTeplyBATargeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProc Natl Acad Sci U S A20061036315632016606824
  • Brannon-PeppasLBlanchetteJONanoparticle and targeted systems for cancer therapyAdv Drug Deliv Rev2004561649165915350294
  • GuFXKarnikRWangAZTargeted nanoparticles for cancer therapyNano Today200721421
  • PeerDKarpJMHongSNanocarriers as an emerging platform for cancer therapyNat Nanotechnol2007275176018654426
  • FournierRLBasic Transport Phenomena in Biomedical EngineeringNew York, NYTaylor & Francis2007
  • SaltzmanWMDrug Delivery: Engineering Principles for Drug TherapyNew York, NYOxford University Press2001
  • NasongklaNBeyERenJMultifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systemsNano Lett200662427243017090068
  • WinterPMCaruthersSDKassnerAMolecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu) beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imagingCancer Res2003635838584314522907
  • DevarajNKKeliherEJThurberGM18F labeled nanoparticles for in vivo PET-CT imagingBioconjugate Chemistry20092039740119138113
  • RenkinEMFiltration, diffusion, and molecular sieving through porous cellulose membranesJ Gen Physiol19543822524313211998
  • OgstonAGPrestonBNWellsJDOn the transport of compact particles through solutions of chain-polymers. Proceedings of the Royal Society of London. AMathematical and Physical Sciences1973333297
  • FlennikenMLWillitsDAHarmsenALMelanoma and lymphocyte cell-specific targeting incorporated into a heat shock protein cage architectureChemistry and Biology20061316117016492564
  • BatrakovaEVDorodnychTYKlinskiiEYAnthracycline antibiotics non-covalently incorporated into the block copolymer micelles: In vivo evaluation of anti-cancer activityBr J Cancer199674154515528932333
  • GradisharWJTjulandinSDavidsonNPhase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancerJ Clin Oncol2005237794780316172456
  • WuWWieckowskiSPastorinGTargeted delivery of amphotericin B to cells by using functionalized carbon nanotubesAngewandte Chemie-International Edition20054463586362
  • DecuzziPGodinBTanakaTSize and shape effects in the biodistribution of intravascularly injected particlesJ Control Release201014132032719874859
  • FeronOTumor-penetrating peptides: a shift from magic bullets to magic gunsSci Transl Med2010234
  • ForbesZGYellenBBBarbeeKAFriedmanGAn approach to targeted drug delivery based on uniform magnetic fieldsIEEE Transactions on Magnetics20033933723377
  • KimGJNieSTargeted cancer nanotherapyMaterials Today200582833
  • OriveGHernándezRMGascónARPedrazJLMicro and nano drug delivery systems in cancer therapyCancer Therapy20053131138
  • ParkJHvon MaltzahnGXuMJCooperative nanomaterial system to sensitize, target, and treat tumorsProceedings of the National Academy of Sciences of the United States of America201010798198620080556
  • SugaharaKNTeesaluTKarmaliPPTissue-penetrating delivery of compounds and nanoparticles into tumorsCancer Cell20091651052019962669
  • TanakaTDecuzziPCristofanilliMNanotechnology for breast cancer therapyBiomedical Microdevices200911496318663578
  • GriefADRichardsonGMathematical modeling of magnetically targeted drug deliveryJ Magn Magn Mater2005293455463
  • GangulyRGaindAPSenSPuriIKAnalyzing ferrofluid transport for magnetic drug targetingJ Magn Magn Mater2005289331334
  • VoltairasPAFotiadisDIMichalisLKHydrodynamics of magnetic drug targetingJ Biomech20023581382112021001
  • NacevABeniCBrunoOShapiroBThe behaviors of ferro-magnetic nano-particles in and around blood vessels under applied magnetic fieldsJ Magn Magn Mater201132365166821278859
  • KenneckeHYerushalmiRWoodsRMetastatic behavior of breast cancer subtypesJ Clin Oncol2010283271327720498394
  • TerayamaNTeradaTNakanumaYAn immunohistochemical study of tumour vessels in metastatic liver cancers and the surrounding liver tissueHistopathology19962937438818692
  • TerayamaNTeradaTNakanumaYHistologic growth patterns of metastatic carcinomas of the liverJapanese J Clin Oncol1996262429
  • FeynmanRPLeightonRBSandsMThe Feynman Lectures on PhysicsReading, MAAddison-Wesley Publishing Company1964
  • COMSOL multiphysics user’s guideBurlington, MACOMSOL AB2005
  • TorchilinVPNanoparticulates as Drug CarriersLondon, UKImperial College Press, Distributed by World Scientific Pub2006
  • RosensweigREFerrohydrodynamicsMineola, NYDover Publications, Inc1985
  • IncroperaFPFundamentals of Heat and Mass TransferHoboken, NJJohn Wiley2007
  • LubbeASBergemannCHuhntWPreclinical experiences with magnetic drug targeting: tolerance and efficacyCancer Res199656469447018840986
  • LubbeASBergemannCRiessHClinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumorsCancer Res199656468646938840985
  • AlagkiozidisIFacciabeneATsiatasMTime-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapyJ Transl Med201197721609494
  • HorwitzSBTaxol (paclitaxel): mechanisms of actionAnn Oncol19945S37865431
  • LorussoDPietragallaAMainentiSReview role of topotecan in gynaecological cancers: current indications and perspectivesCrit Rev Oncol Hematol7416317419766512
  • MiniENobiliSCaciagliBCellular pharmacology of gemcitabineAnn Oncol200617v716807468
  • DuffullSBRobinsonBAClinical pharmacokinetics and dose optimisation of carboplatinClin Pharmacokinet1997331619314610
  • LemkeAJvon PilsachMISLubbeAMRI after magnetic drug targeting in patients with advanced solid malignant tumorsEur Radiol2004141949195515300401
  • NacevABeniCBrunoOShapiroBMagnetic nanoparticle transport within flowing blood and into surrounding tissueNanomedicine201051459146621128726
  • ShapiroBEmmert-BuckMRShapiroBMethods and systems using therapeutic, diagnostic or prophylactic magnetic agents May 192008
  • PantonRLIncompressible Flow2 edNew York, NYJohn Wiley & Sons, Inc1996
  • YellenBBForbesZGBarbeeKAFriedmanGModel of an approach to targeted drug delivery based on uniform magnetic fieldsPaper presented at Magnetics Conference2003INTERMAG 2003IEEE International2003
  • SarwarANemirovskiAShapiroBOptimal Halbach permanent magnet designs for maximally pulling and pushing nanoparticlesJ Magn Magn Mater2010 In press
  • DobsonJMagnetic nanoparticles for drug deliveryDrug Dev Res2006675560
  • ShapiroBTowards dynamic control of magnetic fields to focus magnetic carriers to targets deep inside the bodyJ Magn Magn Mater20093211594159920165553
  • ShapiroBProbstRPottsHEDynamic control of magnetic fields to focus drug-coated nano-particles to deep tissue tumors7th International Conference on the Scientific and Clinical Applications of Magnetic CarriersVancouver, BC2008